Most cited documents in this series:

Year	Title	Cited
2005	Should Patients Have a Greater Role in Valuing Health States? RePEc:wkh:aheahp:v:4:y:2005:i:4:p:201-208 [Citation Analysis]	8
2005	What is Required to Evaluate the Impact of Pharmaceutical Reference Pricing? RePEc:wkh:aheahp:v:4:y:2005:i:2:p:87-98 [Citation Analysis]	8
2004	The Reliability of Willingness to Pay for Changes in Health Status RePEc:wkh:aheahp:v:3:y:2004:i:1:p:35-38 [Citation Analysis]	5
2004	How Much Might Universal Health Insurance Reduce Socioeconomic Disparities in Health?: A Comparison of the US and Canada RePEc:wkh:aheahp:v:3:y:2004:i:4:p:205-216 [Citation Analysis]	5
2006	To Retain or Remove User Fees?: Reflections on the Current Debate in Low- and Middle-Income Countries RePEc:wkh:aheahp:v:5:y:2006:i:3:p:137-153 [Citation Analysis]	3
2004	The Impact of Physician Payment Methods on Raising the Efficiency of the Healthcare System: An International Comparison RePEc:wkh:aheahp:v:3:y:2004:i:1:p:39-46 [Citation Analysis]	3
2006	Impact of Cross-Reference Pricing on Pharmaceutical Prices: Manufacturers Pricing Strategies and Price Regulation RePEc:wkh:aheahp:v:5:y:2006:i:4:p:235-247 [Citation Analysis]	3
2005	Key Performance Indicators for the Implementation of Social Health Insurance RePEc:wkh:aheahp:v:4:y:2005:i:1:p:15-22 [Citation Analysis]	2
2004	Is Patient Choice an Effective Mechanism to Reduce Waiting Times? RePEc:wkh:aheahp:v:3:y:2004:i:4:p:195-203 [Citation Analysis]	2
2004	The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement RePEc:wkh:aheahp:v:3:y:2004:i:2:p:79-89 [Citation Analysis]	2
2005	Procedural Justice in Public Healthcare Resource Allocation RePEc:wkh:aheahp:v:4:y:2005:i:2:p:119-127 [Citation Analysis]	2
2005	The Australian Health Policy Changes of 1999 and 2000: An Evaluation RePEc:wkh:aheahp:v:4:y:2005:i:4:p:229-238 [Citation Analysis]	2
2004	Modelling the Ability of Risk Adjusters to Reduce Adverse Selection in Managed Care RePEc:wkh:aheahp:v:3:y:2004:i:2:p:107-114 [Citation Analysis]	2
2004	Consumer Mobility in Social Health Insurance Markets: A Five-Country Comparison RePEc:wkh:aheahp:v:3:y:2004:i:4:p:229-241 [Citation Analysis]	2
2005	Can Privatising Selected Services Benefit the Public Healthcare System?: The Greek Case RePEc:wkh:aheahp:v:4:y:2005:i:3:p:153-157 [Citation Analysis]	2
2006	Estimating Technical Efficiency in the Hospital Sector with Panel Data: A Comparison of Parametric and Non-Parametric Techniques RePEc:wkh:aheahp:v:5:y:2006:i:2:p:99-116 [Citation Analysis]	2
2005	Handling Missing Data in Patient-Level Cost-Effectiveness Analysis alongside Randomised Clinical Trials RePEc:wkh:aheahp:v:4:y:2005:i:2:p:65-75 [Citation Analysis]	2
2006	Quality and Cost in Healthcare: A Relationship Worth Examining RePEc:wkh:aheahp:v:5:y:2006:i:4:p:201-208 [Citation Analysis]	1
2005	Comparing the Preferences of Health Professionals and Members of the Public for Setting Healthcare Priorities: Experiences from Australia RePEc:wkh:aheahp:v:4:y:2005:i:2:p:129-137 [Citation Analysis]	1
2005	Determining Priority for Liver Transplantation: A Comparison of Cost per QALY and Discrete Choice Experiment-Generated Public Preferences RePEc:wkh:aheahp:v:4:y:2005:i:4:p:249-255 [Citation Analysis]	1
2008	The Impact of Direct-to-Consumer Advertised Drugs on Drug Sales in the US and New Zealand RePEc:wkh:aheahp:v:6:y:2008:i:2-3:p:93-102 [Citation Analysis]	1
2004	Tackling Regional Health Inequalities in France by Resource Allocation: A Case for Complementary Instrumental and Process-Based Approaches? RePEc:wkh:aheahp:v:3:y:2004:i:4:p:243-250 [Citation Analysis]	1
2005	Methodological Challenges Posed by Economic Evaluations of Early Childhood Intervention Programmes RePEc:wkh:aheahp:v:4:y:2005:i:3:p:175-181 [Citation Analysis]	1
2006	Patients Preferences for Healthcare System Reforms in Hungary: A Conjoint Analysis RePEc:wkh:aheahp:v:5:y:2006:i:3:p:189-198 [Citation Analysis]	1
2004	Do Patients Always Prefer Quicker Treatment?: A Discrete Choice Analysis of Patients RePEc:wkh:aheahp:v:3:y:2004:i:4:p:183-194 [Citation Analysis]	1
2010	The Effect of Protest Zeros on Estimates of Willingness to Pay in Healthcare Contingent Valuation Analysis RePEc:wkh:aheahp:v:8:y:2010:i:4:p:225-237 [Citation Analysis]	1
2008	Wealth Status and Risky Sexual Behaviour in Ghana and Kenya RePEc:wkh:aheahp:v:6:y:2008:i:1:p:27-39 [Citation Analysis]	1
2004	Listening to the Decision Makers: Sustainability of PBMA in Alberta RePEc:wkh:aheahp:v:3:y:2004:i:3:p:143-151 [Citation Analysis]	1
2010	Health System Choice: A Pilot Discrete-Choice Experiment Eliciting the Preferences of British and Australian Citizens RePEc:wkh:aheahp:v:8:y:2010:i:2:p:89-97 [Citation Analysis]	1
2005	A Wolf Dressed in Sheeps Clothing: Perhaps Quality Measures are Just Unmeasured Severity RePEc:wkh:aheahp:v:4:y:2005:i:1:p:55-64 [Citation Analysis]	1
2005	What Value Health?: A Review of Health State Values Used in Early Technology Assessments for NICE RePEc:wkh:aheahp:v:4:y:2005:i:4:p:219-228 [Citation Analysis]	1
2004	Healthcare Payment Incentives: A Comparative Analysis of Reforms in Taiwan, South Korea and China RePEc:wkh:aheahp:v:3:y:2004:i:1:p:47-56 [Citation Analysis]	1
2006	Maximising Responses to Discrete Choice Experiments: A Randomised Trial RePEc:wkh:aheahp:v:5:y:2006:i:4:p:249-260 [Citation Analysis]	1
2004	Senior Citizens and the Burden of Prescription Drug Outlays: What Lessons for the Medicare Prescription Drug Benefit? RePEc:wkh:aheahp:v:3:y:2004:i:4:p:217-227 [Citation Analysis]	1
2004	Calculating Society RePEc:wkh:aheahp:v:3:y:2004:i:3:p:125-126 [Citation Analysis]	1
2009	Which Barriers Prevent the Efficient Use of Resources in Medical Device Sectors? RePEc:wkh:aheahp:v:7:y:2009:i:4:p:209-217 [Citation Analysis]	1
2005	Decentralisation Strategies and Provider Incentives in Healthcare: Evidence from the English National Health Service RePEc:wkh:aheahp:v:4:y:2005:i:1:p:47-54 [Citation Analysis]	1
2005	How to Present the Business Case for Healthcare Quality to Employers RePEc:wkh:aheahp:v:4:y:2005:i:4:p:209-218 [Citation Analysis]	1
2006	The Relationship between Ex Ante Mortality Risk and End-of-Life Medical Costs RePEc:wkh:aheahp:v:5:y:2006:i:1:p:37-44 [Citation Analysis]	1
2004	EQ-5D versus SF-6D in an Older, Chronically Ill Patient Group RePEc:wkh:aheahp:v:3:y:2004:i:2:p:91-102 [Citation Analysis]	1
2009	Soft Regulations in Pharmaceutical Policy Making: An Overview of Current Approaches and their Consequences RePEc:wkh:aheahp:v:7:y:2009:i:3:p:137-147 [Citation Analysis]	1

Citing documents used to compute impact factor 3:

Year	Title	See
2011	The influence of information and private versus public provision on preferences for screening for prostate cancer: A willingness-to-pay study RePEc:eee:hepoli:v:101:y:2011:i:3:p:277-289	[Citation Analysis]
2011	Communities of color? Client-to-client racial concordance in the selection of mental health programs for Caucasians and African Americans RePEc:kap:hcarem:v:14:y:2011:i:4:p:314-323	[Citation Analysis]
2011	Introduction and uptake of new medical technologies in the Australian health care system: A qualitative study RePEc:eee:hepoli:v:102:y:2011:i:2:p:152-158	[Citation Analysis]

Cites in year: CiY